E3-Independent Constitutive Monoubiquitination Complements Histone Methyltransferase Activity of SETDB1

Molecular Cell

Volumn 62, Issue 6, 2016, Pages 958-966

  Sun, Lidong ^a   Fang, Jia ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; ENZYME; ENZYME 1; ENZYME 2; ENZYME 3; HISTONE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE H3K9; HISTONE SETDB1; LYSINE; UNCLASSIFIED DRUG; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; PROTEIN METHYLTRANSFERASE; SETDB1 PROTEIN, HUMAN; SETDB1 PROTEIN, MOUSE; UBIQUITIN CONJUGATING ENZYME;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONJUGATION; EMBRYONIC STEM CELL; ENDOGENOUS RETROVIRUS; ENZYME ACTIVITY; ENZYME MECHANISM; GENE SILENCING; HISTONE METHYLATION; HUMAN; LIGATION; NONHUMAN; PROTEIN FUNCTION; UBIQUITINATION; WESTERN BLOTTING; ANIMAL; CATALYSIS; CHEMICAL PHENOMENA; CHEMISTRY; CRISPR CAS SYSTEM; DNA METHYLATION; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HELA CELL LINE; MCF-7 CELL LINE; METABOLISM; MOUSE; PROTEIN CONFORMATION; PROTEIN MOTIF; STRUCTURE ACTIVITY RELATION;

AMINO ACID MOTIFS; ANIMALS; CATALYSIS; CRISPR-CAS SYSTEMS; DNA METHYLATION; EMBRYONIC STEM CELLS; ENDOGENOUS RETROVIRUSES; GENE SILENCING; HEK293 CELLS; HELA CELLS; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LYSINE; MCF-7 CELLS; MICE; PROTEIN CONFORMATION; PROTEIN METHYLTRANSFERASES; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITINATION;

EID: 84969921435     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2016.04.022     Document Type: Article

References (34)

1. Bilodeau S., Kagey M.H., Frampton G.M., Rahl P.B., Young R.A. SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state. Genes Dev. 2009, 23:2484-2489.
2. Ceol C.J., Houvras Y., Jane-Valbuena J., Bilodeau S., Orlando D.A., Battisti V., Fritsch L., Lin W.M., Hollmann T.J., Ferre F., et al. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 2011, 471:513-517.
3. Chen Z.J., Sun L.J. Nonproteolytic functions of ubiquitin in cell signaling. Mol. Cell 2009, 33:275-286.
4. Dikic I., Wakatsuki S., Walters K.J. Ubiquitin-binding domains - from structures to functions. Nat. Rev. Mol. Cell Biol. 2009, 10:659-671.
5. Dodge J.E., Kang Y.K., Beppu H., Lei H., Li E. Histone H3-K9 methyltransferase ESET is essential for early development. Mol. Cell. Biol. 2004, 24:2478-2486.
6. Fei Q., Shang K., Zhang J., Chuai S., Kong D., Zhou T., Fu S., Liang Y., Li C., Chen Z., et al. Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53. Nat. Commun. 2015, 6:8651.
7. Hans F., Fiesel F.C., Strong J.C., Jackel S., Rasse T.M., Geisler S., Springer W., Schulz J.B., Voigt A., Kahle P.J. UBE2E ubiquitin-conjugating enzymes and ubiquitin isopeptidase Y regulate TDP-43 protein ubiquitination. J. Biol. Chem. 2014, 289:19164-19179.
8. Hoeller D., Hecker C.M., Wagner S., Rogov V., Dotsch V., Dikic I. E3-independent monoubiquitination of ubiquitin-binding proteins. Mol. Cell 2007, 26:891-898.
9. Husnjak K., Dikic I. Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu. Rev. Biochem. 2012, 81:291-322.
10. Jackson S.P., Durocher D. Regulation of DNA damage responses by ubiquitin and SUMO. Mol. Cell 2013, 49:795-807.
11. Kokura K., Sun L., Bedford M.T., Fang J. Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing and promotes tumour cell motility and invasion. EMBO J. 2010, 29:3673-3687.
12. Komander D., Rape M. The ubiquitin code. Annu. Rev. Biochem. 2012, 81:203-229.
13. Komander D., Clague M.J., Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 2009, 10:550-563.
14. Li M., Chen D., Shiloh A., Luo J., Nikolaev A.Y., Qin J., Gu W. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 2002, 416:648-653.
15. Liu S., Brind'Amour J., Karimi M.M., Shirane K., Bogutz A., Lefebvre L., Sasaki H., Shinkai Y., Lorincz M.C. Setdb1 is required for germline development and silencing of H3K9me3-marked endogenous retroviruses in primordial germ cells. Genes Dev. 2014, 28:2041-2055.
16. Martin C., Zhang Y. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol. 2005, 6:838-849.
17. Matsui T., Leung D., Miyashita H., Maksakova I.A., Miyachi H., Kimura H., Tachibana M., Lorincz M.C., Shinkai Y. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature 2010, 464:927-931.
18. Polo S., Sigismund S., Faretta M., Guidi M., Capua M.R., Bossi G., Chen H., De Camilli P., Di Fiore P.P. A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins. Nature 2002, 416:451-455.
19. Ramanathan H.N., Ye Y. Cellular strategies for making monoubiquitin signals. Crit. Rev. Biochem. Mol. Biol. 2012, 47:17-28.
20. Ran F.A., Hsu P.D., Wright J., Agarwala V., Scott D.A., Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 2013, 8:2281-2308.
21. Reyes-Turcu F.E., Ventii K.H., Wilkinson K.D. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 2009, 78:363-397.
22. Ryu H., Lee J., Hagerty S.W., Soh B.Y., McAlpin S.E., Cormier K.A., Smith K.M., Ferrante R.J. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc. Natl. Acad. Sci. USA 2006, 103:19176-19181.
23. Sanjana N.E., Shalem O., Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 2014, 11:783-784.
24. Schultz D.C., Ayyanathan K., Negorev D., Maul G.G., Rauscher F.J. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev. 2002, 16:919-932.
25. Sigismund S., Polo S., Di Fiore P.P. Signaling through monoubiquitination. Curr. Top. Microbiol. Immunol. 2004, 286:149-185.
26. Sowa M.E., Bennett E.J., Gygi S.P., Harper J.W. Defining the human deubiquitinating enzyme interaction landscape. Cell 2009, 138:389-403.
27. Stegmeier F., Rape M., Draviam V.M., Nalepa G., Sowa M.E., Ang X.L., McDonald E.R., Li M.Z., Hannon G.J., Sorger P.K., et al. Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature 2007, 446:876-881.
28. Wang H., An W., Cao R., Xia L., Erdjument-Bromage H., Chatton B., Tempst P., Roeder R.G., Zhang Y. mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression. Mol. Cell 2003, 12:475-487.
29. Wenzel D.M., Stoll K.E., Klevit R.E. E2s: structurally economical and functionally replete. Biochem. J. 2011, 433:31-42.
30. Wu H., Min J., Lunin V.V., Antoshenko T., Dombrovski L., Zeng H., Allali-Hassani A., Campagna-Slater V., Vedadi M., Arrowsmith C.H., et al. Structural biology of human H3K9 methyltransferases. PLoS ONE 2010, 5:e8570.
31. Xiao B., Wilson J.R., Gamblin S.J. SET domains and histone methylation. Curr. Opin. Struct. Biol. 2003, 13:699-705.
32. Yang C., Tan W., Whittle C., Qiu L., Cao L., Akbarian S., Xu Z. The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism. PLoS ONE 2010, 5:e15878.
33. Ye Y., Rape M. Building ubiquitin chains: E2 enzymes at work. Nat. Rev. Mol. Cell Biol. 2009, 10:755-764.
34. Yuan P., Han J., Guo G., Orlov Y.L., Huss M., Loh Y.H., Yaw L.P., Robson P., Lim B., Ng H.H. Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells. Genes Dev. 2009, 23:2507-2520.